Skip to Content
Menu
About
Science
EDO Platform
Scientific Publications
Pipeline
Overview
Clinical Trials
Expanded Access Policy
Community
Community Stories
DMD
DM1
Careers
Investors
News
Contact
Nonclinical Data for PGN-EDODM1 Demonstrated Nuclear Delivery, Mechanistic and Meaningful Activity for the Potential Treatment of DM1
Post navigation
Previous:
Nonclinical in vitro and in vivo data demonstrated low immunogenicity risk and favorable of PGN-EDO51 for the treatment of DMD
Next:
Single- and Repeat-Dose Nonclinical Data for PGN-EDO51 Demonstrated Favorable Pharmacology and Safety Profiles for the Treatment of DMD
